Stock CVM.H CVR MEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials CVR Medical Corp.

Equities

CVM.H

CA1266321084

Biotechnology & Medical Research

Delayed Toronto S.E.
Other stock markets
 03:12:33 2022-05-05 pm EDT 		5-day change 1st Jan Change
0.015 CAD -25.00% Intraday chart for CVR Medical Corp. -.--% -.--%
2022 CVR Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
2022 CVR Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI

Valuation

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Capitalization 1 12.01 18.06 20.57 18.79 2.48 3.605
Enterprise Value (EV) 2 11.88 17.47 20.52 18.93 2.841 4.039
P/E ratio -2.76 x -1.9 x -1.81 x -2.88 x -11.5 x -1.55 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA - -2,743,443 x -3,233,280 x -3,824,661 x -83,119,296 x -7,452,621 x
EV / FCF -21.1 x -4.51 x -10.6 x -175 x -9.28 x 32.3 x
FCF Yield -4.74% -22.2% -9.4% -0.57% -10.8% 3.09%
Price to Book 8.95 x 8.89 x 99.2 x -8.45 x -0.92 x -0.81 x
Nbr of stocks (in thousands) 41,523 64,938 112,378 126,378 126,378 130,228
Reference price 3 0.2893 0.2780 0.1830 0.1487 0.0196 0.0277
Announcement Date 4/27/17 4/27/18 8/23/19 8/11/20 4/30/21 7/14/22
1USD in Million2CAD in Million3USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales - - - - - -
EBITDA - -6.369 -6.347 -4.949 -0.0342 -0.5419
EBIT 1 -2.384 -6.369 -6.347 -4.95 -0.0344 -0.5422
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -3.008 -8.494 -7.442 -5.137 -0.1734 -1.818
Net income 1 -3.008 -8.494 -7.442 -5.137 -0.1734 -1.818
Net margin - - - - - -
EPS 2 -0.1046 -0.1463 -0.1012 -0.0516 -0.001710 -0.0179
Free Cash Flow 1 -0.5631 -3.873 -1.929 -0.1084 -0.306 0.125
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/27/17 4/27/18 8/23/19 8/11/20 4/30/21 7/14/22
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt 1 - - - 0.14 0.36 0.43
Net Cash position 1 0.13 0.58 0.05 - - -
Leverage (Debt/EBITDA) - - - -0.0287 x -10.54 x -0.8006 x
Free Cash Flow 1 -0.56 -3.87 -1.93 -0.11 -0.31 0.12
ROE (net income / shareholders' equity) -684% -504% -815% 511% 7.06% 50.9%
ROA (Net income/ Total Assets) -181% -210% -255% -239% -1.77% -51.5%
Assets 1 1.663 4.053 2.913 2.152 9.793 3.532
Book Value Per Share 2 0.0300 0.0300 0 -0.0200 -0.0200 -0.0300
Cash Flow per Share 2 0 0.0100 0 0 0 0
Capex - 0 - - - -
Capex / Sales - - - - - -
Announcement Date 4/27/17 4/27/18 8/23/19 8/11/20 4/30/21 7/14/22
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Diagnostics & Testing

1st Jan change Capi.
CVR MEDICAL CORP. Stock CVR Medical Corp.
-.--% 1.45M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-20.55% 10.81B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+47.97% 3.36B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-32.75% 2.22B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-14.15% 2.16B
VERACYTE, INC. Stock Veracyte, Inc.
-26.06% 1.55B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+19.85% 1.04B
SEEGENE, INC. Stock Seegene, Inc.
-2.62% 746M
CAREDX, INC Stock CareDx, Inc
-31.67% 425M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-43.88% 405M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. CVM.H Stock
  4. Financials CVR Medical Corp.